Published in Proc Natl Acad Sci U S A on June 07, 1994
Arginine metabolism: nitric oxide and beyond. Biochem J (1998) 6.44
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71
Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol (2003) 1.35
Biomechanical thresholds regulate inflammation through the NF-kappaB pathway: experiments and modeling. PLoS One (2009) 1.21
Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A (1996) 1.11
Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology (1997) 1.02
Attenuation of host NO production by MAMPs potentiates development of the host in the squid-vibrio symbiosis. Cell Microbiol (2011) 0.99
Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J Clin Invest (1995) 0.94
Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J (1999) 0.92
Immunostaining for cell picking and real-time mRNA quantitation. Am J Pathol (2000) 0.91
Cyclic AMP inhibits IL-1beta plus IFNgamma-induced NF-kappaB translocation in hepatocytes by a PKA independent mechanism. J Surg Res (2009) 0.87
Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J (1994) 0.86
Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis. Br J Pharmacol (1995) 0.86
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi. World J Gastroenterol (2006) 0.86
Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP. Br J Pharmacol (1996) 0.85
Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells. Biochem J (1996) 0.84
Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase. Br J Pharmacol (2000) 0.84
Interleukin 1 beta and cAMP trigger the expression of GTP cyclohydrolase I in rat renal mesangial cells. Biochem J (1996) 0.83
Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. J Clin Invest (1997) 0.83
Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP. Gut (1999) 0.79
Interleukin-1beta inhibits ATP-induced protein kinase B activation in renal mesangial cells by two different mechanisms: the involvement of nitric oxide and ceramide. Br J Pharmacol (2003) 0.79
Inhibition of cytokine-induced inducible nitric oxide synthase expression by glucagon and cAMP in cultured hepatocytes. Biochem J (1997) 0.79
Inhibition of NFkappaB-mediated pro-inflammatory gene expression in rat mesangial cells by the enolized 1,3-dioxane-4, 6-dione-5-carboxamide, CGP-43182. Br J Pharmacol (2000) 0.78
Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol (1997) 0.77
Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells. Br J Pharmacol (1996) 0.75
Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation. Mediators Inflamm (1997) 0.75
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A (1986) 15.20
Nitric oxide as a secretory product of mammalian cells. FASEB J (1992) 13.38
Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (1992) 9.01
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (1991) 8.41
Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 6.92
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32
Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem (1992) 4.88
Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci (1991) 4.66
Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A (1992) 4.32
Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med (1993) 4.06
Nitric oxide, a novel biologic messenger. Cell (1992) 3.04
Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res (1986) 2.68
Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46
Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med (1990) 1.62
Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol (1990) 1.51
Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun (1991) 1.42
Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun (1991) 1.39
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol (1990) 1.38
Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol (1993) 1.20
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20
Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett (1990) 1.20
Cross-talk between transmembrane signalling systems: a prerequisite for the delicate regulation of glomerular haemodynamics by mesangial cells. Eur J Clin Invest (1989) 1.18
Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron (1993) 1.03
Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler (1992) 1.01
Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett (1992) 0.98
Anti-inflammatory steroids inhibit cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur J Pharmacol (1991) 0.90
Platelet-derived growth factor inhibits cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur J Pharmacol (1991) 0.83
Estimating the cots required for neonatal intensive care. Arch Dis Child (1981) 2.73
Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J (2001) 2.52
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol (2000) 2.42
Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci U S A (1987) 2.29
Islet-cell antibodies in diabetes mellitus. Lancet (1976) 2.20
Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J (2001) 2.06
Incidence of familial melanoma and MLM2 gene. Lancet (1994) 2.03
Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol (1998) 2.00
Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem (2000) 1.94
Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions--a case for screening all patients? J Hosp Infect (2007) 1.89
When do pregnant women attend for antenatal care? Br Med J (1980) 1.88
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta (2000) 1.77
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Mitochondrial antibodies (AMA). Gut (1974) 1.60
Measurement of glycosylated hemoglobin on cellulose acetate membranes by mobile affinity electrophoresis. Clin Chem (1983) 1.58
Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol (1999) 1.58
The morbidity of long-term seizure monitoring using subdural strip electrodes. J Neurosurg (1991) 1.53
Vascular access for hemodialysis in children. Pediatr Nephrol (1997) 1.48
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
Immunopathology of liver disease. Prog Liver Dis (1972) 1.47
Who cares for Missouri's Medicaid nursing home residents? Characteristics of attending physicians. J Am Geriatr Soc (1993) 1.47
Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut (1974) 1.47
Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest (2000) 1.45
Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology (1987) 1.42
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab (2001) 1.42
[The prevention of osteoporosis]. Dtsch Med Wochenschr (2001) 1.39
Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet (1975) 1.38
Acid resistance of enamel subsurface lesions remineralized by a sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. Caries Res (2004) 1.38
ON THE LACK OF EVIDENCE OF TRANSMISSION BY HUMAN BEINGS OF TUBERCULOSIS DUE TO THE BOVINE TYPE OF BACILLUS. Br Med J (1934) 1.38
The dynamics of interorganizational coordination. Adm Sci Q (1984) 1.35
Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A (1996) 1.34
Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut (1979) 1.32
Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J (2004) 1.31
The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol (1999) 1.29
Distributed situation awareness in dynamic systems: theoretical development and application of an ergonomics methodology. Ergonomics (2006) 1.29
Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci U S A (1986) 1.25
Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A (1988) 1.20
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J (1999) 1.16
I. Sarcoma of the Kidney in Children: A Critical Review of the Pathology, Symptomatology, Prognosis, and Operative Treatment as seen in One Hundred and Forty-five Cases. Ann Surg (1897) 1.16
Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol (1998) 1.14
Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem J (1986) 1.14
Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured rat renal mesangial cells. Biochem J (1986) 1.13
Ultrastructural changes in the small intestine induced by ethanol. Gastroenterology (1972) 1.12
Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures. Biochem J (1984) 1.12
Rectally administered prednisolone--evidence for a predominantly local action. Gut (1980) 1.12
The fine structure of the frontal filament complex of barnacle larvae (Crustacea: cirripedia). Cell Tissue Res (1974) 1.11
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest (2001) 1.11
Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A (1996) 1.11
Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol (1994) 1.10
Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int (2006) 1.10
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res (1999) 1.10
Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol (1997) 1.09
Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J (1995) 1.09
Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol (2009) 1.08
A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol (1986) 1.08
A case of testicular lupus. Lupus (2000) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
What do patients and their carers want to know about stroke? A two-year follow-up study. Clin Rehabil (1998) 1.07
Tumour promotor 12-O-tetradecanoylphorbol 13-acetate inhibits angiotensin II-induced inositol phosphate production and cytosolic Ca2+ rise in rat renal mesangial cells. FEBS Lett (1986) 1.07
Inducible NO synthase: role in cellular signalling. J Exp Biol (1999) 1.06
Periprosthetic metastatic carcinoma. Pitfalls in the management of two cases initially diagnosed as osteolysis. J Arthroplasty (1996) 1.06
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand (2007) 1.06
Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun (2000) 1.06
Selective inhibition of cyclooxygenase 2. Biochem Pharmacol (1994) 1.06
Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J (2000) 1.05
Problems in the early recognition of congenital hip dislocation. Br Med J (1971) 1.04
Role of protein kinase C in inhibition of renin release caused by vasoconstrictors. Am J Physiol (1986) 1.04
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA. Structure (2001) 1.04
Serum antibodies in human pancreatic disease. Gut (1975) 1.04
Transport and communication systems in health services. Trop Doct (1977) 1.03
Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron (1993) 1.03
Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res (1991) 1.03
Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells. Biochemistry (1998) 1.02
The early management of varus feet in myelomeningocele. J Bone Joint Surg Br (1971) 1.01
Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J Biol Chem (2001) 1.01
Dermatomyositis associated with multifocal lipoatrophy. J Am Acad Dermatol (1990) 1.01
Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J Biol Chem (1999) 1.01
Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. J Biol Chem (1992) 1.00
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J (2000) 1.00
Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun (1991) 1.00
Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J (2001) 1.00
Effect of extracellular ATP on contraction, cytosolic calcium activity, membrane voltage and ion currents of rat mesangial cells in primary culture. Br J Pharmacol (1993) 1.00
Hypoxia and cobalt stimulate lactate dehydrogenase (LDH) activity in vascular smooth muscle cells. Pflugers Arch (1994) 1.00
Protein kinase C phosphorylates and activates GTP cyclohydrolase I in rat renal mesangial cells. Biochem Biophys Res Commun (1998) 1.00
A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol (2001) 0.99
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin. Arterioscler Thromb Vasc Biol (2000) 0.98
Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int (1999) 0.98